| 000 | 00897 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513075332.0 | ||
| 264 | 0 | _c19931110 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0009-9279 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSinger, D E | |
| 245 | 0 | 0 |
_aProblems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation. _h[electronic resource] |
| 260 |
_bClinical research _cOct 1993 |
||
| 300 |
_a482-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdrug therapy |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstandards |
| 650 | 0 | 4 | _aTherapeutic Human Experimentation |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 773 | 0 |
_tClinical research _gvol. 41 _gno. 3 _gp. 482-6 |
|
| 999 |
_c8403051 _d8403051 |
||